A randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairment.
Evaluate safety and efficacy of Incobotulinumtoxin A in elderly patients with dementia and paratonia.University-affiliated hospital, spasticity management Clinic.Ten subjects were enrolled.1) severe cognitive impairment 2) diagnosis of Alzheimer's disease, vascular dementia, or frontotemporal d...
Main Authors: | Galit Kleiner-Fisman, Edwin Khoo, Nikohl Moncrieffe, Triina Forbell, Pearl Gryfe, David Fisman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4275182?pdf=render |
Similar Items
-
A Patient-Based Needs Assessment for Living Well with Parkinson Disease: Implementation via Nominal Group Technique
by: Galit Kleiner-Fisman, et al.
Published: (2013-01-01) -
Health-Related Quality of Life in Parkinson disease: Correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans
by: Kleiner-Fisman Galit, et al.
Published: (2010-08-01) -
Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.
by: Carmen Gasca-Salas, et al.
Published: (2016-01-01) -
Botulinum toxin
by: Nigam P, et al.
Published: (2010-01-01) -
Botulinum Toxin
Published: (2018)